Source: Coinspeaker
Johnson & Johnson has commenced a phase 3 trial of its one-shot vaccine. The company will recruit a total of 60,000 participants.
Johnson & Johnson begins final stage of clinical trials for potential coronavirus vaccine
Source: Washington Examiner
Johnson & Johnson’s potential vaccine for the novel coronavirus entered the final stage of clinical trials, the fourth vaccine candidate to be designated as Phase III by the Trump administration’s Operation Warp Speed.
Johnson & Johnson Enters Phase 3 Trial for Single-Dose Coronavirus Vaccine
Source: Slate
Multiple vaccines will likely be required to vaccinate billions of people to sufficiently suppress the virus.
Johnson & Johnson’s stock rallies after Phase 3 trial launched for COVID-19 vaccine candidate
Source: MarketWatch
Shares of Johnson & Johnson undefined rallied 2.2% in premarket trading Wednesday, after the health care and pharmaceutical company said it launched its…
Johnson & Johnson’s coronavirus vaccine is fourth to begin Phase 3 trials in the United States
Source: CNN
Johnson & Johnson’s Covid-19 vaccine candidate begins Phase 3 trials in the United States today. Trials for the single-dose vaccine will include up to 60,000 adult participants at nearly 215 sites in the US and internationally.
Johnson & Johnson Begins Phase 3 Trial of Covid-19 Vaccine
Source: New York Times
Unlike some of its competitors, Johnson & Johnson’s vaccine does not need to be frozen and may require just one shot instead of two.
Genmab shares drop on legal battle with J&J over cancer drug
Source: Reuters Latin America
Shares in Danish biotech firm Genmab <GMAB.CO> fell as much as 14% on Wednesday after it said it was locked in a legal battle with its partner Johnson & Johnson <JNJ.N> over royalty payments for its key cancer drug.
JOHNSON & JOHNSON EXPECTS 7-9% GROWTH OF PHARMA MARKET IN UKRAINE
Source: Ukraine open for business
Johnson & Johnson Ukraine predicts a 7-9% growth in the pharmaceutical market in 2021, Johnson & Johnson Country Manager Denis Golubchykov has said.
Trump hints that PFIZER’s coronavirus vaccine could be first approved
Source: Daily Mail Online
‘Pfizer’s doing really well,’ Trump said in a Fox News interview. ‘Johnson & Johnson…they’ll probably be a little later.’ Vaccine czar Dr Moncef Slaoui said vulnerable Americans may get a shot by December.
Healthcare stocks plunge amid broad market rout as Ruth Bader Ginsburg’s death creates uncertainty around Obamacare
Source: Business Insider
Summary List Placement Heathcare stocks tanked on Monday after the death of Justice Ruth Bader Ginsburg threw the future of the Affordable Care Act into jeopardy. The Trump administration’s challenge to the ACA is set to reach the Supreme Court on November 10. With Trump and Senate Republicans rushing to fill Ginsburg’s seat, a strengthened conservative majority is far more likely to reverse the law. Sector giants including Johnson & Johnson , UnitedHealth Group , and Amgen tumbled through the session. Several analysts lowered ratings on healthcare stocks, saying Ginsburg’s death clouded revenue estimates. Visit the Business Insider homepage for more stories . Healthcare stocks tumbled on Monday after the death of Justice Ruth Bader Ginsburg sparked concerns that the Supreme Court may dismantle Obamacare and roil the health insurance industry. Senate Republicans and the Trump administration have already set out to fill Ginsburg’s court seat ahead of the US presidential election in November.
